InsiderFlow

Robert E. Waltermire

MDGL

Robert E. Waltermire serves as Senior VP, Chief Pharma Dev. at Madrigal Pharmaceuticals, Inc. (MDGL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

8 trades

$6.02M

Net Position

Net Seller

$6.02M

Companies Traded

1

MDGL

Active Period

Mar 2023 – Jan 2025

8 total trades

Most Recent

Sell MDGL

Jan 27, 2025 · $34.5K

Robert E. Waltermire's Insider Trading at Madrigal Pharmaceuticals, Inc. (MDGL)

Buys

0 · $0.00

Sells

8 · $6.02M

Total Shares Bought

0

Total Shares Sold

23,281

MDGL Price Chart
Loading chart...
DateTypeValue
Jan 27, 2025 Sell$34.5K
Jan 17, 2025 Sell$120.8K
Jun 18, 2024 Sell$532.0K
Jun 14, 2024 Sell$570.0K
May 23, 2024 Sell$239.7K
Dec 18, 2023 Sell$942.0K
Dec 14, 2023 Sell$846.7K
Mar 2, 2023 Sell$2.73M